Casdin Capital, LLC
Source: SEC Form 13F · as of Mar 2026Casdin Capital, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $654.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$654.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for REVOLUTION MEDICINES, INC. (RVMD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| RVMDREVOLUTION MEDICINES, INC. | 2,577,333 | $250.6M |
| RLAYRelay Therapeutics, Inc. | 14,418,574 | $143.5M |
| GPCRStructure Therapeutics Inc. | 1,175,000 | $56.6M |
| DNLIDenali Therapeutics Inc. | 1,840,000 | $35.3M |
| BEAMBeam Therapeutics Inc. | 1,350,000 | $32.2M |
| NGNENeurogene Inc. | 1,420,361 | $28.6M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 75,000 | $24.8M |
| MAZEMaze Therapeutics, Inc. | 758,857 | $22.7M |
| SRRKScholar Rock Holding Corp | 350,000 | $17.2M |
| AGMBAgomAb Therapeutics NV | 1,550,000 | $16.3M |
| MLTXMoonLake Immunotherapeutics | 450,000 | $8.4M |
| NTLAIntellia Therapeutics, Inc. | 355,000 | $4.6M |
| IRONDisc Medicine, Inc. | 65,000 | $4.2M |
| MRNAModerna, Inc. | 75,000 | $3.8M |
| ABSIAbsci Corporation | 973,260 | $2.9M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 282,312 | $2.5M |
| RXRXRECURSION PHARMACEUTICALS, INC. | 165,323 | $508K |
| DNAGinkgo Bioworks Holdings Inc. | 36,493 | $224K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.